TRANSDERMAL PREPARATIONS AND METHOD FOR RELIEVING SIDE EFFECTS IN PERGOLIDE THERAPY

摘要

It is intended to provide pergolide-containing transdermal preparations having relieved side effects and exerting sufficient therapeutic effects. Namely, a pergolide-containing transdermal preparation which is capable of achieving a plasma AUC ratio of pergolide or the like to at least one pergolide metabolite of 1:0.5 to 1:5; and/or a transdermal preparation containing pergolide and/or a pharmaceutically acceptable salt thereof which is capable of achieving a ratio (A/B) of the maximum plasma level (A) of pergolide and/or a pharmaceutically acceptable salt thereof to the plasma level (B) thereof in the next administration of less than 2.